SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-318949
Filing Date
2013-08-05
Accepted
2013-08-05 15:42:34
Documents
6
Period of Report
2013-07-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d580668d8k.htm 8-K 21119
2 EX-1.1 d580668dex11.htm EX-1.1 251285
3 EX-5.1 d580668dex51.htm EX-5.1 6388
4 EX-99.1 d580668dex991.htm EX-99.1 5743
5 EX-99.2 d580668dex992.htm EX-99.2 5666
6 GRAPHIC g580668bio_logo.jpg GRAPHIC 7553
  Complete submission text file 0001193125-13-318949.txt   301888
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 131010151
SIC: 2836 Biological Products, (No Diagnostic Substances)